1. 1813 Interaction of TP53 mutations with trastuzumab in HER2-positive patients with operable breast cancer. (September 2015) Authors: Kotoula, V.; Zagouri, F.; Alexopoulou, Z.; Gogas, H.; Lakis, S.; Pentheroudakis, G.; Bobos, M.; Papadopoulou, K.; Tsolaki, E.; Skondra, M.; Karavasilis, V.; Koutras, A.; Chrisafi, S.; Christodoulou, C.; Papakostas, P.; Linardou, H.; Markopoulos, C.; Zografos, G.; Samantas, E.; Fountzilas, G. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S270 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 2549 Treatment patterns in patients (pts) with metastatic castrationresistant prostate cancer (mCRPC) previously treated with docetaxel (DOC)-based chemotherapy (CT): PROXIMA 1-year analysis. (September 2015) Authors: Akaza, H.; Procopio, G.; Pripatnanont, C.; Facchini, G.; Fava, S.; Wheatley, D.; Leung, K.C.; Butt, M.; Silva, A.; Castillo, L.; Karavasilis, V.; Hitier, S.; Ecstein-Fraisse, E.B.; Bensfia, S.; roglu, M. Ö zgü Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S492 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Clinicopathologic study of vascular endothelial growth factor, thrombospondin-1, and microvessel density assessed by CD34 in patients with stage III ovarian carcinoma. (1st January 2006) Authors: Karavasilis, V.; Malamou-Mitsi, V.; Briasoulis, E.; Tsanou, E.; Kitsou, E.; Pavlidis, N. Journal: International journal of gynecological cancer Issue: Volume 16(2006)Supplement 1 Page Start: 241 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗